2009
DOI: 10.1016/j.ccc.2009.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Steroid Therapy of Septic Shock

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
19
0

Year Published

2010
2010
2014
2014

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(19 citation statements)
references
References 33 publications
0
19
0
Order By: Relevance
“…The beneficial role of adrenal activation during cardiac arrest is supported by the high adrenocorticotropic hormone levels in successfully resuscitated cardiac arrest patients [14] and low serum cortisol levels in patients with early post-resuscitation mortality [11]. In addition, steroids potentiate the effects of the vasoconstrictors by facilitating intracellular signaling by vasoconstrictor receptors [15,16]. …”
Section: Commentarymentioning
confidence: 99%
“…The beneficial role of adrenal activation during cardiac arrest is supported by the high adrenocorticotropic hormone levels in successfully resuscitated cardiac arrest patients [14] and low serum cortisol levels in patients with early post-resuscitation mortality [11]. In addition, steroids potentiate the effects of the vasoconstrictors by facilitating intracellular signaling by vasoconstrictor receptors [15,16]. …”
Section: Commentarymentioning
confidence: 99%
“…Despite their potential benefits, corticosteroids have adverse affects and the benefits and risks, e.g. superinfections and critical illness polyneuromyopathy, must be balanced in order to determine whether they should be used or not [30]. Conversely, experimental and clinical studies have demonstrated a strong cause and effect relationship between persistence versus reduction in systemic inflammation and progression of ALI/ARDS.…”
Section: Corticosteroidsmentioning
confidence: 99%
“…septic shock; sepsis; corticosteroids; adrenal insufficiency; cortisol; adrenocorticotropic hormone; aldosterone "RELATIVE ADRENAL DEFICIENCY" in critically ill patients with otherwise normal hypothalamic-pituitary-adrenal (HPA) function was recently renamed "critical illness-related corticosteroid insufficiency" (CIRCI) (33). However, there are no widely accepted criteria for the diagnosis and treatment of this hypothetical condition (40,41,57,58). No test of HPA function reliably predicts outcome, and the relative importance of endogenous glucocorticoid (cortisol) vs. mineralocorticoid (aldosterone) activity to survival is not known.…”
mentioning
confidence: 99%
“…However, there are no widely accepted criteria for the diagnosis and treatment of this hypothetical condition (40,41,57,58). No test of HPA function reliably predicts outcome, and the relative importance of endogenous glucocorticoid (cortisol) vs. mineralocorticoid (aldosterone) activity to survival is not known.…”
mentioning
confidence: 99%